How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

715 results for

Medication Causes of Myositis

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Medication Causes of Myositis

Medication Causes of Myositis Medication Causes of Myositis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Medication Causes (...) of Myositis Medication Causes of Myositis Aka: Medication Causes of Myositis , Toxic Myopathy , Drug Induced Myositis , Muscle Weakness due to Medications II. Causes Antithyroid medications s Chemotherapeutics Emetine s ( agents) Interferon Leuprolide (Lupron) s Niflumic acid Phenylbutazone medications (e.g. ) s III. References Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Medication Causes of Myositis." Click on the image (or right

2018 FP Notebook

2. Myositis Ossificans of the Hip Due to Pyogenic Arthritis Caused by Campylobacter fetus Subspecies fetus (PubMed)

Myositis Ossificans of the Hip Due to Pyogenic Arthritis Caused by Campylobacter fetus Subspecies fetus A 61-year-old woman was admitted with severe hip pain causing immobility and high serum levels of inflammatory markers. The patient had a medical history of diabetes. She had been scheduled to undergo right hip replacement surgery for the treatment of osteoarthritis associated with gradually progressive pain. On admission, an enhanced abdominal computed tomography scan showed an abnormal (...) increase in synovial fluid surrounding the right ilium, with piriformis muscle calcification. Subsequent blood and specimen cultures identified Campylobacter fetus subspecies fetus. This is a rare report of a case of myositis ossificans followed by C. fetus pyogenic arthritis of the hip.

Full Text available with Trip Pro

2017 Internal Medicine

3. Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report (PubMed)

Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that mainly affects the joints, therefore, may cause deformities and disability if untreated. The first line of treatment is disease-modifying antirheumatic drugs (DMARDs). When the patient fails to respond to DMARDs, mainly methotrexate, then second-line therapy is required. Tumor necrosis factor α (TNFα) plays (...) an important role in the pathogenesis of RA; however, the treatment with anti-TNFα medications is challenging. It may trigger the autoimmune system and result in producing antibodies that induce symptoms and signs mimic to systemic lupus erythematosus (SLE), and in rare situations can affect vital organs with severe and life-threatening complications. We report on a 38-year-old Saudi woman with longstanding erosive RA, who was diagnosed based on the 1987 classification criteria. She developed life

Full Text available with Trip Pro

2018 International journal of general medicine

4. Molecular Profile of the Evolution of Inclusion Body Myositis

inflammation (overlap myositis, rheumatoid arthritis, lupus, vasculitis, spondylarthritis, scleroderma, psoriatic arthritis), disease causing nerve-damage (Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis), auto-immune neuropathy (chronic polyradiculoneuritis and variants (multifocal motor neuropathy with conduction blocks, anti-MAG neuropathy)). Presence of the following histological characteristics in the muscle biopsy pointing to degenerative and/or mitochondrial pathologies (...) tissue inflammation (overlap myositis, rheumatoid arthritis, lupus, vasculitis, spondylarthritis, scleroderma, psoriatic arthritis), disease causing nerve-damage (Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis), auto-immune neuropathy (chronic polyradiculoneuritis and variants (multifocal motor neuropathy with conduction blocks, anti-MAG neuropathy)). Patient who received one of the following treatments, prior to the muscle biopsy that confirmed the diagnosis: anti

2017 Clinical Trials

5. Study of Pioglitazone in Sporadic Inclusion Body Myositis

myositis (sIBM) based on the sIBM Diagnostic Criteria established by the 2010 European Neuromuscular Center. Must be able to ambulate at least 20 feet, with or without the use of an assistive device. Patients may not use another person, wall, or furniture for support. Must be able to rise from a chair without support from another person or device. Premenopausal women must have a negative serum pregnancy test prior to dosing with study medication. Women of child-bearing potential and men must agree (...) Study of Pioglitazone in Sporadic Inclusion Body Myositis Study of Pioglitazone in Sporadic Inclusion Body Myositis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study of Pioglitazone in Sporadic

2017 Clinical Trials

6. Clinical Implications and Hospital Outcome of Immune‐Mediated Myositis in Horses (PubMed)

Clinical Implications and Hospital Outcome of Immune‐Mediated Myositis in Horses Immune-mediated myositis (IMM) is a cause of rhabdomyolysis, stiffness, and muscle atrophy predominantly affecting Quarter horses. Limited information is available with regard to outcome, prognostic indicators, and associations with concurrent diseases.To report outcomes and associations between outcome and clinical and laboratory parameters, and presence of concurrent illness.Sixty-eight horses; 52 Quarter (...) horses and related breeds and 16 other breeds.Retrospective cohort study (1991-2014). Medical records of horses with histological diagnosis of IMM were reviewed. Data recovery included signalment, laboratory variables, therapy, and outcome. Logistic regression was used to quantify the association between potential prognostic factors and survival to discharge.Quarter horses were younger (mean < 4 years, range 3 months-21 years) than other breeds (mean < 10 years, range 1-23 years). Pathogens causing

Full Text available with Trip Pro

2017 Journal of Veterinary Internal Medicine

7. Medication Causes of Myositis

Medication Causes of Myositis Medication Causes of Myositis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Medication Causes (...) of Myositis Medication Causes of Myositis Aka: Medication Causes of Myositis , Toxic Myopathy , Drug Induced Myositis , Muscle Weakness due to Medications II. Causes Antithyroid medications s Chemotherapeutics Emetine s ( agents) Interferon Leuprolide (Lupron) s Niflumic acid Phenylbutazone medications (e.g. ) s III. References Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Medication Causes of Myositis." Click on the image (or right

2015 FP Notebook

8. Ankylosing Neurogenic Myositis Ossificans of the Hip: A Case Series and Review of Literature (PubMed)

Ankylosing Neurogenic Myositis Ossificans of the Hip: A Case Series and Review of Literature Neurogenic myositis ossificans (NMO) in patients with traumatic spinal cord or brain injuries can cause severe joint ankylosis or compromise neurovascularture. The purpose of this study was to evaluate the clinical and radiological outcomes of and review considerations relevant to surgical resection of NMO of the hip joint.Six patients (9 hips) underwent periarticular NMO resection between 2015 and 2017 (...) . The medical records of these patients were retrospectively reviewed. Preoperative computed tomography including angiography was performed to determine osteoma location and size. Improvement in hip motion allowing sitting was considered the sole indicator of a successful surgery. The anterior approach was used in all patients. The ranges of motion (ROM) before and after surgery were compared.The mean time from accident to surgery was 3.6 years. Average ROM improved from 24.3°(flexion and extension) to 98.5

Full Text available with Trip Pro

2018 Hip & pelvis

9. Acute renal failure due to Dengue myositis: a rare cause of pigment cast nephropathy (PubMed)

Acute renal failure due to Dengue myositis: a rare cause of pigment cast nephropathy 26120463 2015 06 29 2018 11 13 2048-8505 6 6 2013 Dec Clinical kidney journal Clin Kidney J Acute renal failure due to Dengue myositis: a rare cause of pigment cast nephropathy. 662-3 10.1093/ckj/sft119 Uthamalingam P P Department of Pathology , Post Graduate Institution of Medical Education and Research (PGIMER) , Chandigarh , India. Nada R R Department of Histopathology , PGIMER , Chandigarh , India

Full Text available with Trip Pro

2013 Clinical kidney journal

10. American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty Arthritis Care & Research Vol. 69, No. 8, August 2017, pp 1111–1124 DOI 10.1002/acr.23274 V C 2017, American College of Rheumatology SPECIAL ARTICLE 2017 American College of Rheumatology/ American Association of Hip and Knee Surgeons Guideline (...) for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty SUSAN M. GOODMAN, 1 BRYAN SPRINGER, 2 GORDON GUYATT, 3 MATTHEW P. ABDEL, 4 VINOD DASA, 5 MICHAEL GEORGE, 6 ORA GEWURZ-SINGER, 7 JON T. GILES, 8 BEVERLY JOHNSON, 9 STEVE LEE, 10 LISA A. MANDL, 1 MICHAEL A. MONT, 11 PETER SCULCO, 1 SCOTT SPORER, 12 LOUIS STRYKER, 13 MARAT TURGUNBAEV, 14 BARRY BRAUSE, 1 ANTONIA F. CHEN, 15 JEREMY GILILLAND, 16 MARK GOODMAN, 17 ARLENE

2017 American College of Rheumatology

11. Spinal fusion and antibiotic treatment illustrating lumbar osteomyelitis and spinal instability as a previously unrecognized and surgically treatable cause of autonomic dysreflexia (PubMed)

retention. We present a case of a C6-7 tetraplegic who developed AD 20 years after his injury with the unusual trigger of positional spinal instability due to osteomyelitis and discitis. The patient's clinical course began when he was diagnosed with L2-3 and L3-4 osteomyelitis, discitis and myositis of the bilateral paraspinous muscles. The infection did not respond well to an attempted course of medical management and degenerated into an unstable spinal segment. This instability in the vertebral column (...) Spinal fusion and antibiotic treatment illustrating lumbar osteomyelitis and spinal instability as a previously unrecognized and surgically treatable cause of autonomic dysreflexia Autonomic dysreflexia (AD) following spinal cord injury can lead to a physiologic state where there is unopposed sympathetic tone and subsequent hypertension, bradycardia, hyperhidrosis and anxiety. It is known to be triggered by nociceptive stimuli below the level of injury-most commonly constipation and bladder

Full Text available with Trip Pro

2016 Spinal cord series and cases

12. Infectious Myositis (Treatment)

Infectious Myositis (Treatment) Infectious Myositis Treatment & Management: Medical Care, Surgical Care, Consultations Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTE2ODE2Ny10cmVhdG1lbnQ= processing (...) > Infectious Myositis Treatment & Management Updated: Jan 13, 2018 Author: Mohammed J Zafar, MD, FAAN, FACP, FASN; Chief Editor: Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM Share Email Print Feedback Close Sections Sections Infectious Myositis Treatment Medical Care All medical care should be provided in conjunction with an infectious disease specialist and the primary care physician. HIV polymyositis: Corticosteroids remain the mainstay of treatment of polymyositis. Trichinosis Thiabendazole is effective

2014 eMedicine.com

13. Inclusion Body Myositis (Treatment)

Inclusion Body Myositis (Treatment) Inclusion Body Myositis Treatment & Management: Medical Care, Surgical Care, Consultations Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTE3Mjc0Ni10cmVhdG1lbnQ= processing (...) > Inclusion Body Myositis Treatment & Management Updated: Jun 08, 2018 Author: Michael P Collins, MD; Chief Editor: Nicholas Lorenzo, MD, MHA, CPE Share Email Print Feedback Close Sections Sections Inclusion Body Myositis Treatment Medical Care No definitive treatment has been proven effective for s-IBM. Early anecdotal reports documented the failure of patients to respond to steroids, methotrexate, azathioprine, and cyclophosphamide. Subsequent clinical studies of various immunosuppressive

2014 eMedicine.com

14. Infectious Myositis (Overview)

), fungi, and parasites can cause myositis. For a detailed discussion of HIV-associated myopathies, refer to . Next: Pathophysiology Single or multiple muscle groups in the limbs can be involved, a notable exception being trichinosis, which commonly involves orbital muscles. In most instances, involvement of proximal muscles is predominant. Characteristic myopathic features and findings of polymyositis, including inflammatory infiltrates, may be seen. Viruses: Viruses implicated in the pathogenesis (...) in California. Human infection results from the bite of infected ticks in the late spring and early summer. Lyme myositis may result from direct invasion of muscle by the spirochete Borrelia burgdorferi or by autoimmune mechanisms. [ ] Ixodes scapularis (dammini), tick vector for Lyme disease. Courtesy of Centers for Disease Control and Prevention. American trypanosomiasis: The causative organism is a protozoan, Trypanosoma cruzi. The insect vectors are reduviid bugs such as Rhodnius prolixus ("vinchuca

2014 eMedicine.com

15. Inclusion Body Myositis (Overview)

findings of sporadic inclusion body myositis (s-IBM) involve both inflammatory and degenerative characteristics, and the true primary pathogenesis of the disease remains a subject of significant debate. Theoretically, the possibilities include (1) a primary T-cell mediated autoimmune response causing muscle damage, (2) a primary degenerative process involving abnormal protein processing leading to a secondary inflammatory response, and (3) separate and independent immune and degenerative processes (...) , of normal. [ ] Dysphagia due to weakness of the cricopharyngeal musculature may predispose individuals to . Mortality rate is difficult to assess based on current data. Affected individuals tend to be older, the disease is insidious and chronic, and patients often die of other medical problems. In a population-based study, the mean age of death of patients with s-IBM was not significantly different from that of the general population. Cause of death was disease-related (aspiration pneumonia

2014 eMedicine.com

16. Inclusion Body Myositis (Follow-up)

precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci U S A . 1996 Feb 6. 93(3):1314-9. . . Dalakas MC. Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol . 1998 Dec. 55(12):1509-12. . Parker KC, Kong SW, Walsh RJ, Salajegheh M, Moghadaszadeh B, Amato AA, et al. Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis. Muscle Nerve . 2009 Jun. 39(6):739-53. . . Ferrer I (...) Inclusion Body Myositis (Follow-up) Inclusion Body Myositis Follow-up: Further Outpatient Care, Complications, Prognosis Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTE3Mjc0Ni1mb2xsb3d1cA== processing

2014 eMedicine.com

17. Myositis Ossificans (Diagnosis)

Chief, Division of Pediatric Rheumatology, Children's National Medical Center Lawrence K Jung, MD is a member of the following medical societies: , , , , Disclosure: Nothing to disclose. What would you like to print? What would you like to print? Sections Pediatric Fibrodysplasia Ossificans Progressiva (Myositis Ossificans) Find Us On About Membership WebMD Network Editions All material on this website is protected by copyright, Copyright © 1994-2019 by WebMD LLC. This website also contains material (...) Myositis Ossificans (Diagnosis) Pediatric Fibrodysplasia Ossificans Progressiva (Myositis Ossificans): Background, Pathophysiology, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache

2014 eMedicine Pediatrics

18. Myositis Ossificans (Treatment)

Myositis Ossificans (Treatment) Pediatric Fibrodysplasia Ossificans Progressiva (Myositis Ossificans) Treatment & Management: Medical Care, Surgical Care, Activity Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache (...) =aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTAwNzEwNC10cmVhdG1lbnQ= processing > Pediatric Fibrodysplasia Ossificans Progressiva (Myositis Ossificans) Treatment & Management Updated: Aug 14, 2018 Author: Robert J Pignolo, MD, PhD; Chief Editor: Lawrence K Jung, MD Share Email Print Feedback Close Sections Sections Pediatric Fibrodysplasia Ossificans Progressiva (Myositis Ossificans) Treatment Medical Care Flare-ups of fibrodysplasia ossificans progressiva (FOP) are sporadic and unpredictable, and the rate of individual disease progression widely varies

2014 eMedicine Pediatrics

19. Myositis Ossificans (Overview)

Rheumatology, Children's National Medical Center Lawrence K Jung, MD is a member of the following medical societies: , , , , Disclosure: Nothing to disclose. What would you like to print? What would you like to print? Sections Pediatric Fibrodysplasia Ossificans Progressiva (Myositis Ossificans) Find Us On About Membership WebMD Network Editions All material on this website is protected by copyright, Copyright © 1994-2019 by WebMD LLC. This website also contains material copyrighted by 3rd parties. Close (...) Myositis Ossificans (Overview) Pediatric Fibrodysplasia Ossificans Progressiva (Myositis Ossificans): Background, Pathophysiology, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTAwNzEwNC1vdmVydmlldw

2014 eMedicine Pediatrics

20. Infectious Myositis (Diagnosis)

), fungi, and parasites can cause myositis. For a detailed discussion of HIV-associated myopathies, refer to . Next: Pathophysiology Single or multiple muscle groups in the limbs can be involved, a notable exception being trichinosis, which commonly involves orbital muscles. In most instances, involvement of proximal muscles is predominant. Characteristic myopathic features and findings of polymyositis, including inflammatory infiltrates, may be seen. Viruses: Viruses implicated in the pathogenesis (...) in California. Human infection results from the bite of infected ticks in the late spring and early summer. Lyme myositis may result from direct invasion of muscle by the spirochete Borrelia burgdorferi or by autoimmune mechanisms. [ ] Ixodes scapularis (dammini), tick vector for Lyme disease. Courtesy of Centers for Disease Control and Prevention. American trypanosomiasis: The causative organism is a protozoan, Trypanosoma cruzi. The insect vectors are reduviid bugs such as Rhodnius prolixus ("vinchuca

2014 eMedicine.com

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>